{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fthe-dime-177afd40.simplecast.com%2Fepisodes%2Fhow-charlottes-web-unlocked-medical-cbd-4gFNsabo","width":444,"version":"1.0","type":"rich","title":"How Charlotte’s Web Unlocked Medical CBD ft. Bill Morachnick","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/1a0a47e2-85d2-449a-9d9b-559883abfdcb/9dcf3518-cd67-4e0f-9f5c-c21c9ce295e3/dime-cover-art-new-v2.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"","height":200,"description":"Before CBD was discussed by a President in the Oval Office, it was a medical necessity.\n\nThe Charlotte Figi story is well documented — and powerful.Not because it was emotional, but because it forced a serious medical conversation.\n\nStories like Charlotte’s change how physicians, regulators, and institutions think about where cannabinoid therapy belongs — not as a last resort, but as a legitimate option.\n\nCharlotte’s Web was built around that reality. By recognizing that cannabis does have medicinal properties — and that patients should have access to a plant-based option when it can materially improve quality of life — the company focused on trust, standards, and medical credibility first.\n\nThis week, we sit down with Bill Morachnick to break down:\n\nWhy CBD earned acceptance through medical trust, not consumer marketing\nHow physician comfort, reimbursement pathways, and standards changed the conversation\nCBD in the Oval Office — and what that signals for the future of cannabis\n\n\n\nChapters\n\n00:00 Introduction to Charlotte's Web and Bill Morachnick\n\n03:00 The Inspiring Story of Charlotte Figi\n\n05:51 The Executive Order and Its Implications\n\n08:59 The Role of Education in CBD Acceptance\n\n12:12 Challenges and Misconceptions in the Cannabis Industry\n\n15:03 The Future of CBD and Medical Recommendations\n\n18:06 The Impact of Federal Reimbursement on CBD\n\n21:08 Defloria and the Future of Cannabis Research\n\n24:01 Navigating Regulatory Changes and Industry Challenges\n\n27:03 The Importance of Quality and Consistency in CBD Products\n\n30:02 The Potential for Pharmaceutical Collaborations\n\n33:04 Looking Ahead: The Future of CBD and Cannabis\n\n36:13 Final Thoughts and Audience Engagement\n\nSummary\n\nIn this episode, Bryan Fields interviews Bill Morachnick, CEO of Charlotte's Web, discussing the company's inspiring origins, the recent executive order regarding CBD, and the future of cannabis as a medicinal product. Bill shares the powerful story of Charlotte Figi, whose life was transformed by CBD, and emphasizes the importance of education in changing perceptions about cannabis. The conversation also touches on the challenges faced by the industry, the potential for pharmaceutical collaborations, and the impact of federal reimbursement on CBD products.\n\nGuest Links:\n\nhttps://www.trycharlottesweb.com/\nhttps://www.charlottesweb.com/\nhttps://www.youtube.com/charlotteswebcbd\nhttps://www.instagram.com/charlotteswebcbd/\nhttps://www.linkedin.com/in/bill-morachnick-01318a6/\nhttps://www.linkedin.com/company/charlottesweb/\n\nOur Links:\n\nBryan Fields on Twitter\n\nKellan Finney on Twitter\n\nThe Dime on Twitter\n\nExtraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.\n\nAt Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.\n\nThe Dime is a top 5% most shared global podcast\n\nThe Dime is a top 10 Cannabis Podcast \n\nThe Dime has a New Website. Shhhh its not finished.\n\n🎥 YouTube:  The Dime\n\n📸 Instagram:  The Dime\n\nhttps://www.newton-insights.com/\n\n"}